Atlas Trials

Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)

Clinical trial NCT00684892 · COMPLETED

Trial details

NCT number
NCT00684892
Sponsor
Pulmonx Corporation
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Heterogeneous Emphysema
Start date
2008-05-01
Primary completion
2008-11-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.